Article
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Strong Bullish
88.6
−100 Bearish
0
+100 Bullish
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Strong Bullish
88.6
−100Neutral+100
More Like This